Regen BioPharma Inc (RGBP)

[Schuller]

Obviously I have a strong belief in this company but there are holes that could use filling. Their management team is solid with knowledge and past successes. They also have brilliant doctors who are top in their individual fields.

Lander has said the company hates dilution but need to pay the bills to advance the science. They believe the dilution is a small sacrifice to the eventual outcome.

My beef with them is the pace of progress. We are waiting now for the exact same news we were waiting for this time last year. DcellVac little progress, Orphan drug status still in limbo. Promising partnerships still unknown.

However all may start coming in together and quickly and someone jumping on board now may have saved themselves a couple years of anguish.

Best regards!
Schuller.